U.S. federal trademark · Serial No. 88325946
Therapeutic pharmaceutical for the treatment of autoimmune disease and cancer; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease and cancer; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease and cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.